Liraglutide and the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first-episode psychosis: protocol for a pilot trial
Abstract Background People with severe mental illness (SMI) are two to three times more likely to be overweight and obese than the general population and this is associated with significant morbidity and premature mortality. Although lifestyle interventions can support people with SMI to lose weight...
Main Authors: | Clare Alexandra Whicher, Hermione Clare Price, Peter Phiri, Shanaya Rathod, Katharine Barnard-Kelly, Claire Reidy, Kerensa Thorne, Carolyn Asher, Robert Peveler, Joanne McCarthy, Richard Ian Gregory Holt |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | Trials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13063-019-3689-5 |
Similar Items
-
Liraglutide and the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first-episode psychosis: protocol for a pilot trial
by: Whicher, CA, et al.
Published: (2019) -
Liraglutide overdose: A case report and an updated review
by: Sharafaldeen Bin Nafisah, et al.
Published: (2020-01-01) -
Liraglutide Drug Loading with Double Layered Hydroxide- Synthesis and Characterization
by: Sevan Adeeb Doshan, et al.
Published: (2020-06-01) -
Liraglutide and Exercise: A Possible Treatment for Obesity?
by: Ana Paula Azevêdo Macêdo, et al.
Published: (2022-08-01) -
Efficacy and safety of liraglutide in Indian adolescents with obesity
by: I. S. Kochar, et al.
Published: (2019-06-01)